Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 6:50 PM
Ignite Modification Date: 2025-12-25 @ 4:22 PM
NCT ID: NCT02680457
Description: None
Frequency Threshold: 0
Time Frame: From the beginning of the study until a month after the end of the intervention for each patient, an average of 2 months
Study: NCT02680457
Study Brief: Effect of Insulin Degludec Versus Insulin Glargine on Glycemic Variability in Patients With Type 2 Diabetes Mellitus
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Insulin Glargine Patients with Type 2 Diabetes mellitus Insulin Glargine: 10 IU SC every 24 hours for 6 days 0 None 0 12 9 12 View
Insulin Degludec Patients with Type 2 Diabetes mellitus Insulin Degludec: 10 IU SC every 24 hours for 6 days 0 None 0 12 6 12 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders None View
Lower limb paresthesias SYSTEMATIC_ASSESSMENT Nervous system disorders None View
Flatulence SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Mild hypoglycemia SYSTEMATIC_ASSESSMENT Endocrine disorders None View